Aphton Corporation
Results of phase II study of G17DT vaccine reported
Published in Food and Drug Law Weekly, June 25th, 2004
The study showed that G17DT immunization was capable of raising functional antibodies to gastrin 17 in patients with gastric adenocarcinoma. Immunization was well tolerated with no evidence of autoimmune reaction or development of immunological tolerance by repeated immunization. A multicenter phase III trial is ongoing testing G17DT in combination with the chemotherapeutic gemcitabine for the treatment of patients with advanced pancreatic cancer.
The primary...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly
More Articles from Food and Drug Law Weekly
- Abbott Laboratories
Zemplar (Paricalcitol Injection) receives FDA approval for pediatric use - American Medical Systems Holdings, Inc.
FDA clears minimally invasive treatment for bladder condition - American Pharmaceutical Partners, Inc.
FDA approves ANDA for Terbutaline Sulfate Injection - Athena Feminine Technologies
Funding enables study to improve women's ability to have orgasm - Baxter Healthcare Corporation
FDA warning letter issued on promotional materials for Advate - Bayer Pharmaceuticals Corporation
FDA approves Avelox (moxifloxacin HCI) for community-acquired pneumonia - More from this issue of Food and Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
